AMGN

Amgen Inc. News Headlines

$137.494
*  
0.224
0.16%
Get AMGN Alerts
*Delayed - data as of Aug. 27, 2014 14:41 ET  -  Find a broker to begin trading AMGN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    AMGN Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Ligand Pharmaceuticals: Appendix
7/3/2014 12:04:00 PM - Seeking Alpha

Dow Hits 17,000 On Jobs Report; Walgreen Same-Store-Sales Surge 7.5%
7/3/2014 10:41:37 AM - Benzinga

Amgen Gets Breakthrough Therapy Status for Leukemia Drug - Analyst Blog
7/2/2014 5:55:00 PM - Zacks.com

Bind Therapeutics, Amgen End Collaboration on Targeted Cancer Therapy
7/2/2014 4:50:00 PM - Dow Jones Business News

Amgen Receives FDA Breakthrough Therapy Status For Blinatumomab In Leukemia
7/1/2014 8:19:00 AM - RTT News

Motorola Solutions Tops The 20 Best Value Bond Trades With Maturities Of 20 Years Or More
6/30/2014 3:17:00 PM - Seeking Alpha

Amgen Inc. Bonds: A Rare Combination Of Low Risk And High Value
6/30/2014 3:16:00 PM - Seeking Alpha

Bayer Inks Hemophilia Deal with Dimension Therapeutics - Analyst Blog
6/25/2014 4:45:00 PM - Zacks.com

XLV, AMGN, BMY, UNH: Large Outflows Detected at ETF
6/23/2014 11:21:50 AM - BNK Invest

6 Elite Companies In The Spotlight This Week
6/23/2014 7:47:00 AM - Seeking Alpha

Atara Biotherapeutics, Backed by Carlos Slim, Files for IPO
6/20/2014 9:20:00 PM - Dow Jones Business News

Muscle-loss biotech Atara Biotherapeutics files for a $50 million IPO
6/20/2014 6:53:29 PM - Renaissance Capital

Bayer: Nexavar Approved In Japan For Treatment Of Thyroid Cancer - Quick Facts
6/20/2014 3:21:00 AM - RTT News

6 Healthcare Dividend Dogs Dope 10% To 44% June Upsides
6/15/2014 12:41:00 AM - Seeking Alpha

Amgen-AstraZeneca Psoriatic Arthritis Drug Shows Improvement - Analyst Blog
6/12/2014 5:10:00 PM - Zacks.com

Sector Update: Healthcare Shares Flat Pre-Market; Geron Gets Partial Clinical Hold Lifted
6/12/2014 8:57:41 AM - MT Newswires

Sector Update: Healthcare
6/12/2014 8:57:20 AM - MT Newswires

Amgen To Present At Goldman Sachs Conference; Webcast At 4:20 PM ET
6/11/2014 3:00:00 PM - RTT News

BIND Therapeutics Set To Revolutionize Drug Treatment As Clinical Data Continues To Impress
6/11/2014 10:58:00 AM - Seeking Alpha

Wall Street Nervous Amid Overbought Levels, Lack Of Meaningful Cues
6/10/2014 6:35:00 AM - RTT News

3M Finance Chief Departs for Amgen -- 2nd Update
6/9/2014 5:56:00 PM - Dow Jones Business News

Amgen Names David Meline CFO - Update
6/9/2014 5:36:00 PM - RTT News

3M Finance Chief Departs for Amgen -- Update
6/9/2014 4:53:00 PM - Dow Jones Business News

Amgen Appoints David Meline As EVP, CFO - Quick Facts
6/9/2014 4:32:00 PM - RTT News

XLV, AMGN, BMY, UNH: Large Inflows Detected at ETF
6/5/2014 10:57:40 AM - BNK Invest